Authors:
Seyfarth, B
Kuse, R
Sonnen, R
Glass, B
Schmitz, N
Dreger, P
Citation: B. Seyfarth et al., Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?, ANN HEMATOL, 80(7), 2001, pp. 398-405
Authors:
Kuse, R
Colberg, H
Marbe, W
Kodalle, O
Kalmar, P
Lohfert, C
Citation: R. Kuse et al., Which factors render cost-covering lump-sum charging difficult for the treatment of patients with acute leukemias?, ONKOLOGIE, 24(3), 2001, pp. 292-294
Authors:
Hallek, M
Schmitt, B
Wilhelm, M
Busch, R
Krober, A
Fostitsch, HP
Sezer, O
Herold, M
Knauf, W
Wendtner, CM
Kuse, R
Freund, M
Franke, A
Schriever, F
Nerl, C
Dohner, H
Thiel, E
Hiddemann, W
Brittinger, G
Emmerich, B
Citation: M. Hallek et al., Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia, (CLL): results of a phase II study of the German CLL Study Group, BR J HAEM, 114(2), 2001, pp. 342-348
Authors:
Kroger, N
Kruger, W
Renges, H
Zabelina, T
Stute, N
Jung, R
Wittkowsky, G
Kuse, R
Zander, AR
Citation: N. Kroger et al., Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma, BR J HAEM, 112(2), 2001, pp. 421-423
Authors:
Wandt, H
Frank, M
Denzel, T
Aulitzky, W
Bodenstein, H
Brack, N
Duerk, H
Engberding, R
Fauser, A
Geer, T
Germann, B
Gramatzki, M
Kaesberger, J
Kisro, J
Knigge, O
Kochling, G
Kuse, R
Link, H
Neubauer, A
Ohl, S
Pfluger, R
Saal, J
Schakel, U
Schalk, K
Schmidt, H
Soucek, S
Wagner, T
Wilms, K
Winter, R
Ehninger, G
Citation: H. Wandt et al., The 10.000/mu l morning trigger for prophylactic platelet transfusion is safe: Prospective experience in 411 AML patients, HEMAT BLOOD, 40, 2001, pp. 488-490
Authors:
Gahn, B
Brittinger, G
Dolken, G
Dohner, H
Emmerich, B
Franke, A
Freund, M
Huber, C
Kuse, R
Scholten, T
Hiddemann, W
Citation: B. Gahn et al., Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia, LEUK LYMPH, 37(1-2), 2000, pp. 169-173
Authors:
Kroger, N
Zabelina, T
Sonnenberg, S
Kruger, W
Renges, H
Stute, N
Finkenstein, F
Mayer, U
Holstein, K
Fiedler, W
Colberg, H
Sonnen, R
Kuse, R
Braumann, D
Metzner, B
del Valle, F
Erttmann, R
Kabisch, H
Zander, AR
Citation: N. Kroger et al., Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia, BONE MAR TR, 26(7), 2000, pp. 711-716
Authors:
Zhang, W
Knieling, G
Vohwinkel, G
Martinez, T
Kuse, R
Hossfeld, DK
Duhrsen, U
Citation: W. Zhang et al., Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia, ANN HEMATOL, 78(7), 1999, pp. 305-314
Authors:
Dreger, P
Glass, B
Kuse, R
Sonnen, R
von Neuhoff, N
Bolouri, H
Kneba, M
Schmitz, N
Citation: P. Dreger et al., Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia, BR J HAEM, 106(1), 1999, pp. 115-118
Authors:
Kroger, N
Rauhoft, C
Zeller, W
Renges, H
Hassan, HT
Kruger, W
Schuch, G
Wacker-Backhaus, G
Colberg, H
Kuse, R
Gutensohn, K
Loliger, C
Zander, AR
Citation: N. Kroger et al., Efficacy of further attempts to mobilize CD34+peripheral stem cells with alternative procedures after primary failure, ACT HAEMAT, 102(3), 1999, pp. 144-147
Authors:
Kroger, N
Kruger, W
Wacker-Backhaus, G
Hegewisch-Becker, S
Stockschlader, M
Fuchs, N
Russmann, B
Renges, H
Durken, M
Bielack, S
de Wit, M
Schuch, G
Bartels, H
Braumann, D
Kuse, R
Kabisch, H
Erttmann, R
Zander, AR
Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033